Prof. Irit Avivi, M.D. 
Chairman, Tel Aviv Institute of Hematology and Bone Marrow Transplantation, Tel Aviv Medical Center, Israel
Member Professor, Sackler School of Medicine, Tel Aviv University

Prof Irit Avivi serves as the Director of Hematology division at Sourasky Tel Aviv Medical Center.
She was trained in adult Hemato-Oncology at Rambam Medical Center and completed a fellowship in lymphoma and myeloma at London University College Hospitals. She served as the secretory of the Israeli Lymphoma group between 2013-2017.

Her major research and clinical expertise are in prognostication and treatment of myeloma and lymphoma, including the employment of immune- modulating strategies (e.g:  dendritic cell fusion vaccine, regulatory cell depletion, CART cells ect.) and in managing hematological cancers during pregnancy.

She has over 130 scientific publications, has been frequent invited speaker and has won several awards for her immune- translational research in myeloma and Lymphoma. She is running an extensive educational program in Hematology at Tel Aviv Medical Center and has trained more than 20 graduate and postgraduate students over the last decade. She has extensive international collaborations with multiple groups in Europe and USA and is highly involved in many pivotal, phase 1-4 clinical studies in myeloma and lymphoma.

In addition, she has a wide experience in initiating and conducting investigator initiated studies involving multiple centers, exploring new therapeutic approaches for myeloma and lymphoma and involving biomarker studies.